Ewan Millar

Senior Staff Specialist in Anatomical Pathology
Conjoint Associate Professor

Research Interests:
The development of new predictive and prognostic biomarkers for clinical breast cancer; artificial intelligence applications to digital pathology and tissue imaging

Broad Research Areas:
Breast Cancer, Pathology, Biomarkers, Artificial Intelligence, Image analysis

Qualifications:
BSc(Hons) MBChB FRCPath FRCPA MD FFSc(RCPA)

Society Memberships & Professional Activities:
International Academy of Pathology, Australasian Society of Breast Diseases, ANZ Breast Cancer Trials Group

Specific Research Keywords:
Breast Cancer, Breast Pathology

publications

Journal articles
add
Jankovic-Karasoulos T; Bianco-Miotto T; Butler MS; Butler LM; McNeil CM; O'Toole SA; Millar EKA; Sakko AJ; Ruiz AI; Birrell SN; Sutherland RL; Hickey TE; Tilley WD; Ricciardelli C, 2020, 'Elevated levels of tumor apolipoprotein-D independently predict poor outcome in breast cancer patients.', Histopathology, http://dx.doi.org/10.1111/his.14081
2020
Parikh R; Millar E; Phan-Thien KC, 2019, 'A case of amoebic colitis following remote historical exposure', ANZ Journal of Surgery, vol. 89, pp. E222 - E223, http://dx.doi.org/10.1111/ans.14278
2019
Smith HW; Hirukawa A; Sanguin-Gendreau V; Nandi I; Dufour CR; Zuo D; Tandoc K; Leibovitch M; Singh S; Rennhack JP; Swiatnicki M; Lavoie C; Papavasiliou V; Temps C; Carragher NO; Unciti-Broceta A; Savage P; Basik M; van Hoef V; Larsson O; Cooper CL; Vargas Calderon AC; Beith J; Millar E; Selinger C; Giguère V; Park M; Harris LN; Varadan V; Andrechek ER; O’Toole SA; Topisirovic I; Muller WJ, 2019, 'An ErbB2/c-Src axis links bioenergetics with PRC2 translation to drive epigenetic reprogramming and mammary tumorigenesis', Nature Communications, vol. 10, http://dx.doi.org/10.1038/s41467-019-10681-4
2019
Pajic M; Froio D; Daly S; Doculara L; Millar E; Graham PH; Drury A; Steinmann A; De Bock CE; Boulghourjian A; Zaratzian A; Carroll S; Toohey J; O'Toole SA; Harris AL; Buffa FM; Gee HE; Hollway GE; Molloy TJ, 2018, 'miR-139-5p modulates radiotherapy resistance in breast cancer by repressing multiple gene networks of DNA repair and ROS defense', Cancer Research, vol. 78, pp. 501 - 515, http://dx.doi.org/10.1158/0008-5472.CAN-16-3105
2018
Ricciardelli C; Bianco-Miotto T; Jindal S; Butler LM; Leung S; McNeil CM; O'Toole SA; Ebrahimie E; Millar EKA; Sakko AJ; Ruiz AI; Vowler SL; Huntsman DG; Birrell SN; Sutherland RL; Palmieri C; Hickey TE; Tilley WD, 2018, 'The magnitude of androgen receptor positivity in breast cancer is critical for reliable prediction of disease outcome', Clinical Cancer Research, vol. 24, pp. 2328 - 2341, http://dx.doi.org/10.1158/1078-0432.CCR-17-1199
2018
Rogers S; McCloy RA; Parker BL; Gallego-Ortega D; Law AMK; Chin VT; Conway JRW; Fey D; Millar EKA; O’Toole S; Deng N; Swarbrick A; Chastain PD; Cesare AJ; Timpson P; Caldon CE; Croucher DR; James DE; Watkins DN; Burgess A, 2018, 'MASTL overexpression promotes chromosome instability and metastasis in breast cancer', Oncogene, vol. 37, pp. 4518 - 4533, http://dx.doi.org/10.1038/s41388-018-0295-z
2018
Pang JMB; Molania R; Chand A; Knower K; Takano EA; Byrne DJ; Mikeska T; Millar EKA; Lee CS; O'Toole SA; Clyne C; Gorringe KL; Dobrovic A; Fox SB, 2017, 'LRH-1 expression patterns in breast cancer tissues are associated with tumour aggressiveness', Oncotarget, vol. 8, pp. 83626 - 83636, http://dx.doi.org/10.18632/oncotarget.18886
2017
Law AMK; Yin JXM; Castillo L; Young AIJ; Piggin C; Rogers S; Caldon CE; Burgess A; Millar EKA; O'Toole SA; Gallego-Ortega D; Ormandy CJ; Oakes SR, 2017, 'Andy's Algorithms: New automated digital image analysis pipelines for FIJI', Scientific Reports, vol. 7, http://dx.doi.org/10.1038/s41598-017-15885-6
2017
Pang JMB; Savas P; Fellowes AP; Mir Arnau G; Kader T; Vedururu R; Hewitt C; Takano EA; Byrne DJ; Choong DYH; Millar EKA; Soon Lee C; O'Toole SA; Lakhani SR; Cummings MC; Bruce Mann G; Campbell IG; Dobrovic A; Loi S; Gorringe KL; Fox SB, 2017, 'Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancer', Modern Pathology, vol. 30, pp. 952 - 963, http://dx.doi.org/10.1038/modpathol.2017.21
2017
Young AIJ; Law AMK; Castillo L; Chong S; Cullen HD; Koehler M; Herzog S; Brummer T; Lee EF; Fairlie WD; Lucas MC; Herrmann D; Allam A; Timpson P; Watkins DN; Millar EKA; O'Toole SA; Gallego-Ortega D; Ormandy CJ; Oakes SR, 2016, 'MCL-1 inhibition provides a new way to suppress breast cancer metastasis and increase sensitivity to dasatinib', Breast Cancer Research, vol. 18, http://dx.doi.org/10.1186/s13058-016-0781-6
2016
Gallego-Ortega D; Ledger A; Roden DL; Law AMK; Magenau A; Kikhtyak Z; Cho C; Allerdice SL; Lee HJ; Valdes-Mora F; Herrmann D; Salomon R; Young AIJ; Lee BY; Sergio CM; Kaplan W; Piggin C; Conway JRW; Rabinovich B; Millar EKA; Oakes SR; Chtanova T; Swarbrick A; Naylor MJ; O’Toole S; Green AR; Timpson P; Gee JMW; Ellis IO; Clark SJ; Ormandy CJ, 2015, 'ELF5 Drives Lung Metastasis in Luminal Breast Cancer through Recruitment of Gr1+ CD11b+ Myeloid-Derived Suppressor Cells', PLoS Biology, vol. 13, http://dx.doi.org/10.1371/journal.pbio.1002330
2015
Huang KT; Mikeska T; Li J; Takano EA; Millar EKA; Graham PH; Boyle SE; Campbell IG; Speed TP; Dobrovic A; Fox SB, 2015, 'Assessment of DNA methylation profiling and copy number variation as indications of clonal relationship in ipsilateral and contralateral breast cancers to distinguish recurrent breast cancer from a second primary tumour', BMC Cancer, vol. 15, http://dx.doi.org/10.1186/s12885-015-1676-0
2015
Junankar S; Baker LA; Roden DL; Nair R; Elsworth B; Gallego-Ortega D; Lacaze P; Cazet A; Nikolic I; Teo WS; Yang J; McFarland A; Harvey K; Naylor MJ; Lakhani SR; Simpson PT; Raghavendra A; Saunus J; Madore J; Kaplan W; Ormandy C; Millar EKA; O'Toole S; Yun K; Swarbrick A, 2015, 'ID4 controls mammary stem cells and marks breast cancers with a stem cell-like phenotype', Nature Communications, vol. 6, http://dx.doi.org/10.1038/ncomms7548
2015
Gee HE; Buffa FM; Harris AL; Toohey JM; Carroll SL; Cooper CL; Beith J; McNeil C; Carmalt H; Mak C; Warrier S; Holliday A; Selinger C; Beckers R; Kennedy C; Graham P; Swarbrick A; Millar EKA; O'Toole SA; Molloy T, 2015, 'MicroRNA-related DNA repair/cell-cycle genes independently associated with relapse after radiation therapy for early breast cancer', International Journal of Radiation Oncology Biology Physics, vol. 93, pp. 1104 - 1114, http://dx.doi.org/10.1016/j.ijrobp.2015.08.046
2015
Stone A; Zotenko E; Locke WJ; Korbie D; Millar EKA; Pidsley R; Stirzaker C; Graham P; Trau M; Musgrove EA; Nicholson RI; Gee JMW; Clark SJ, 2015, 'DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancer', Nature Communications, vol. 6, http://dx.doi.org/10.1038/ncomms8758
2015
Junankar S; Baker LA; Roden DL; Nair R; Elsworth B; Gallego-Ortega D; Lacaze P; Cazet A; Nikolic I; Teo WS; Yang J; McFarland A; Harvey K; Naylor MJ; Lakhani SR; Simpson PT; Raghavendra A; Saunus J; Madore J; Kaplan W; Ormandy C; Millar EKA; O'Toole S; Yun K; Swarbrick A, 2015, 'ID4 controls mammary stem cells and marks breast cancers with a stem cell-like phenotype', NATURE COMMUNICATIONS, vol. 6, http://dx.doi.org/10.1038/ncomms7548
2015
Beretov J; Wasinger VC; Millar EKA; Schwartz P; Graham PH; Li Y, 2015, 'Proteomic analysis of urine to identify breast cancer biomarker candidates using a label-free LC-MS/MS approach', PLoS ONE, vol. 10, http://dx.doi.org/10.1371/journal.pone.0141876
2015
Pang JMB; Deb S; Takano EA; Byrne DJ; Jene N; Boulghourjian A; Holliday A; Millar E; Lee CS; O'Toole SA; Dobrovic A; Fox SB, 2014, 'Methylation profiling of ductal carcinoma in situ and its relationship to histopathological features', Breast cancer research : BCR, vol. 16, pp. 423, http://dx.doi.org/10.1186/s13058-014-0423-9
2014
Beretov J; Wasinger VC; Graham PH; Millar EK; Kearsley JH; Li Y, 2014, 'Proteomics for breast cancer urine biomarkers', Advances in Clinical Chemistry, vol. 63, pp. 123 - 167, http://dx.doi.org/10.1016/B978-0-12-800094-6.00004-2
2014
Giannakopoulos B; Mirarabshahi P; Qi M; Weatherall C; Qi JC; Tanaka K; Millar E; Vonthethoff L; Gatto D; Spielman D; Krilis SA, 2014, 'Deletion of the antiphospholipid syndrome autoantigen β2- glycoprotein i potentiates the lupus autoimmune phenotype in a toll-like receptor 7-mediated murine model', Arthritis and Rheumatology, vol. 66, pp. 2270 - 2280, http://dx.doi.org/10.1002/art.38646
2014
Gee HE; Froio DA; Doculara LS; Graham PH; Millar EKA; O'Toole SA; Molloy TJ, 2014, 'MicroRNA regulation of radiotherapy sensitivity and resistance in breast cancer', INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, vol. 34, pp. S12 - S12, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000341276000031&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2014
Hau EK; Browne L; Capp AL; Delaney GP; Fox CH; Kearsley J; Millar E; Nasser E; Papadatos G; Graham PH, 2013, 'The impact of breast cosmetic and functional outcomes on quality of life: long-term results from the St. George and Wollongong randomized breast boost trial', Breast Cancer Research and Treatment, vol. 139, pp. 115 - 123, http://dx.doi.org/10.1007/s10549-013-2508-z
2013
O'Toole S; Beith JM; Millar EKA; West R; McLean A; Cazet A; Swarbrick A; Oakes , 2013, 'Therapeutic targets in triple negative breast cancer', Journal of Clinical Pathology, vol. 66, pp. 530 - 542, http://dx.doi.org/10.1136/jclinpath-2012-201361
2013
Schade B; Lesurf R; Sanguin-Gendreau V; Bui T; Deblois G; O'Toole SA; Millar EKA; Zardawi SJ; Lopez-Knowles E; Sutherland RL; Giguère V; Kahn M; Hallett M; Muller WJ, 2013, 'β-catenin signaling is a critical event in ErbB2-mediated mammary tumor progression', Cancer Research, vol. 73, pp. 4474 - 4487, http://dx.doi.org/10.1158/0008-5472.CAN-12-3925
2013
Browne BC; Hochgräfe F; Wu J; Millar EKA; Barraclough J; Stone A; McCloy RA; Lee CS; Roberts C; Ali NA; Boulghourjian A; Schmich F; Linding R; Farrow L; Gee JMW; Nicholson RI; O'Toole SA; Sutherland RL; Musgrove EA; Butt AJ; Daly RJ, 2013, 'Global characterization of signalling networks associated with tamoxifen resistance in breast cancer', FEBS Journal, vol. 280, pp. 5237 - 5257, http://dx.doi.org/10.1111/febs.12441
2013
Chow HT; Tran K; Millar EKA; Lynch J; Murrell DF, 2012, 'Diverse presentations of carcinoma erysipelatoides from a teaching hospital in australia.', Case Rep Dermatol Med, vol. 2012, pp. 134938, http://dx.doi.org/10.1155/2012/134938
2012
Millar E; Graham PH; Mcneil C; Browne L; O''Toole SA; Boulghourjian A; Kearsley J; Papadatos G; Delaney GP; Fox CH; Nasser E; Capp AL; Sutherland R, 2011, 'Prediction of outcome of early ER+ breast cancer is improved using a biomarker panel, which includes Ki-67 and p53panel, which includes Ki-67 and p53', British Journal of Cancer, vol. 105, pp. 272 - 280, http://dx.doi.org/10.1038/bjc.2011.228
2011
O'Toole S; Machalek DA; Shearer R; Millar E; Nair R; Schofield PR; McLeod D; Cooper CE; Mcneil CM; Mcfarland A; Nguyen A; Ormandy CJ; Qiu M; Rabinovich B; Martelotto L; Vu D; Hannigan GE; Musgrove EA; Christ DU; Sutherland RL; Watkins DJ; Swarbrick A, 2011, 'Hedgehog overexpression is associated with stromal interactions and predicts for poor outcome in breast cancer', Cancer research, vol. 71, pp. 4002 - 4014, http://dx.doi.org/10.1158/0008-5472.CAN-10-3738
2011
O'Toole S; Millar E; Selinger CI; LUM T; Beith J, 2011, 'Molecular assays in breast cancer pathology', Pathology, vol. 43, pp. 116 - 127, http://dx.doi.org/10.1097/PAT.0b013e3283430926
2011
Chan P; Moller A; Liu MCP; Sceneay J; Wong CSF; Waddell N; Huang KT; Dobrovic A; Millar E; O'Toole S; Mcneil CM; Sutherland RL; Bowtell DD; Fox S, 2011, 'The expression of the ubiquitin ligase SIAH2 (seven in absentia homolog 2) is mediated through genecopy number in breast cancer and is associated with a basal-like phenotype and p53 expression', Breast Cancer Research, vol. 13, pp. 1 - 10, http://dx.doi.org/10.1186/bcr2828
2011
Yan M; Jene N; Byrne D; Millar E; O'Toole S; Mcneill CM; Bates GJ; Harris AL; Banham AH; Sutherland RL; Fox SB, 2011, 'Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancers', Breast Cancer Research, vol. 13, pp. 1 - 10, http://dx.doi.org/10.1186/bcr2869
2011
Xu H; Yan M; Patra J; Natrajan R; Yan Y; Swagemakers S; Tomaszewski J; Millar E; Spek PVD; Reis-filho J; Ramsay RG; O'Toole S; Mcneil CM; Sutherland RL; McKay MJ; Fox SB, 2011, 'Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancers', Breast Cancer Research, vol. 13, pp. 1 - 10, http://dx.doi.org/10.1186/bcr2814
2011
O'Toole SA; Machalek D; Shearer R; Millar EKA; Nair R; Martelotto L; McLeod D; Cooper C; Qiu MR; Sutherland RL; Watkins DN; Swarbrick A, 2010, 'Hedgehog Ligand Overexpression Predicts Poor Outcome in Breast Cancer and Is a Potential Therapeutic Target for Metastatic Disease', CANCER RESEARCH, vol. 70, http://dx.doi.org/10.1158/0008-5472.SABCS10-S6-8
2010
Fedele CG; Ooms LM; Ho M; Vieusseux J; O'Toole S; Millar EK; Lopez-Knowles E; Sriratana A; Gurung R; Bagliettoe L; Giles GG; Bailey CG; Rasko JEJ; Shields BJ; Price JT; Majerus PW; Sutherland RL; Tiganis T; Mclean ; Mitchell CA, 2010, 'Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers', Proceedings of the National Academy of Sciences of the United States of America, vol. 107, pp. 22231 - 22236, http://dx.doi.org/10.1073/pnas.1015245107
2010
Millar E; Dean J; Mcneil CM; O Toole S; Henshall SM; Tran T; Lin J; Quong A; Comstock C; Witkiewicz A; Musgrove EA; Rui H; Lemarchand L; Setiawan V; Haiman C; Knudsen K; Sutherland RL; Knudsen E, 2009, 'Cyclin D1b protein expression in breast cancer is independent of cyclin D1a and associated with poor disease outcome', Oncogene, vol. 28, pp. 1812 - 1820, http://dx.doi.org/10.1038/onc.2009.13
2009
Yilmaz MH; Millar EK; Theocharous C; Graham PH, 2009, 'Metachronous bilateral primary low-grade mucosa-associated lymphoid tissue non-hodgkins lymphoma of the breast', Asia-Pacific Journal of Clinical Oncology, vol. 5, pp. 154 - 158, http://dx.doi.org/10.1111/j.1743-7563.2009.01230.x
2009
Tan E; Yan M; Campo L; Han CG; Takano E; Turley H; Candiloro I; Pezzella F; Gatter K; Millar E; O Toole S; Mcneil CM; Crea P; Segara D; Sutherland RL; Harris AL; Fox S, 2009, 'The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy', British Journal of Cancer, vol. 100, pp. 405 - 411, http://dx.doi.org/10.1038/sj.bjc.6604844
2009
Millar E; Graham PH; O Toole S; Mcneil CM; Browne L; Morey AL; Eggleton SA; Beretov J; Theocharous C; Capp A; Nasser EH; Kearsley J; Delaney GP; Papadatos G; Fox CH; Sutherland RL, 2009, 'Prediction of Local Recurrence, Distant Metastases, and Death After Breast-Conserving Therapy in Early-Stage Invasive Breast Cancer Using a Five-Biomarker Panel', Journal of Clinical Oncology, vol. 27, pp. 4701 - 4708, http://dx.doi.org/10.1200/JCO.2008.21.7075
2009
Millar E; Anderson LR; Mcneil CM; O Toole S; Pinese M; Crea P; Morey AL; Biankin AV; Henshall SM; Musgrove EA; Sutherland RL; Butt A, 2009, 'BAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breast', British Journal of Cancer, vol. 100, pp. 123 - 133, http://dx.doi.org/10.1038/sj.bjc.6604809
2009
Millar E; Inder SJ; Lynch JP, 2009, 'Extramedullary haematopoiesis in axillary lymph nodes following neoadjuvant chemotherapy for locally advanced breast cancer - A potential diagnostic pitfall', Histopathology, vol. 54, pp. 622 - 623, http://dx.doi.org/10.1111/j.1365-2559.2009.03246.x
2009
Yilmaz M; Millar E; Theocharous C; Graham PH, 2009, 'Metachronous bilateral primary low-grade mucosa-associated lymphoid tissue non-hodgkins lymphoma of the breast', Asia-Pacific Journal of Clinical Oncology, vol. 5, pp. 154 - 158, http://dx.doi.org/10.111/j.1743-7563.2009.01230.x
2009
Wang Y; Dean J; Millar E; Tran T; Mcneil CM; Burd C; Henshall SM; Utama F; Witkiewicz A; Rui H; Sutherland RL; Knudsen K; Knudsen E, 2008, 'Cyclin D1b is aberrantly regulated in response to therapeutic challenge and promotes resistance to estrogen antagonists', Cancer research, vol. 68, pp. 5628 - 5638, http://dx.doi.org/10.1158/0008-5472.CAN-07-3170
2008
Whittaker J; Millar E; Blundell N, 2007, 'Trials in melanoma: Feeling the burn?', Good Clinical Practice Journal, vol. 14, pp. 17 - 20
2007
Millar EKA; Tran K; Marr P; Graham PH, 2007, 'p27KIP-1 cyclin A and cyclin D1 protein expression in ductal carcinoma in situ of the breast: p27KIP-1 correlates with hormone receptor status but not with local recurrence', Pathology International, vol. 57, pp. 183 - 189, http://dx.doi.org/10.1111/j.1440-1827.2007.02079.x
2007
Millar E; Tran K; Marr P; Graham PH, 2007, 'p27KIP-1 cyclin A and cyclin D1 protein expression in ductal carcinoma in situ of the breast: p27KIP-1 correlates with hormone receptor status but not with local recurrence', Pathology International, vol. 57, pp. 183 - 189, http://dx.doi.org/10.1111/j.1440-1827.2007.02079.x
2007
McNeil CM; Sergio CM; Anderson LR; Inman CK; Eggleton SA; Murphy NC; Millar EKA; Crea P; Kench JG; Alles MC; Gardiner-Garden M; Ormandy CJ; Butt AJ; Henshall SM; Musgrove EA; Sutherland RL, 2006, 'c-Myc overexpression and endocrine resistance in breast cancer', Journal of Steroid Biochemistry and Molecular Biology, vol. 102, pp. 147 - 155, http://dx.doi.org/10.1016/j.jsbmb.2006.09.028
2006
Mcneil CM; Anderson LR; Inman CK; Eggleton SA; Murphy NC; Millar E; Crea P; Kench JG; Alles MC; Gardiner-Garden M; Ormandy CJ; Butt A; Henshall SM; Musgrove EA; Sutherland RL; Sergio CM, 2006, 'c-Myc overexpression and endocrine resistance in breast cancer', Journal of Steroid Biochemistry and Molecular Biology, vol. 18, pp. 284 - 289
2006
Graham PH; Jagavkar R; Browne L; Millar E, 2006, 'Supraclavicular radiotherapy must be limited laterally by the coracoid to avoid significant adjuvant breast nodal radiotherapy lymphoedema risk', Journal of Medical Imaging and Radiation Oncology, vol. 50, pp. 578 - 582, http://dx.doi.org/10.1111/j.1440-1673.2006.01658.x
2006
Dray M; McCarthy S; Palmer A; Bonar S; Stalley P; Marjoniemi V; Millar E; Scolyer R, 2006, 'Myopericytoma: a unifying term for a spectrum of tumours that show overlapping features with myofibroma. A review of 14 cases', Journal of Clinical Pathology, vol. 59, pp. 67 - 73, http://dx.doi.org/10.1136/jcp.2005.028704
2006
Murphy N; Millar E; Lee CS, 2005, 'Gene expression profiling in breast cancer: towards individualising patient management', Pathology, vol. 37, pp. 271 - 277, http://dx.doi.org/10.1080/00313020500169586
2005
Trevillian P; Paul H; Millar E; Hibberd A; Agrez MV, 2004, 'αvβ6 integrin expression in diseased and transplanted kidneys', Kidney International, vol. 66, pp. 1423 - 1433, http://dx.doi.org/10.1111/j.1523-1755.2004.00904.x
2004
Trevillian P; Paul H; Millar E; Hibberd AD; Agrez M, 2004, 'A(v)beta(6) integrin expression in diseased and transplanted kidneys', Kidney International, vol. 66, pp. 1423 - 1433, http://dx.doi.org/10.1111/j.1523-1755.2004.00904.x
2004
Millar EKA; Pepperall D; Lee CS; Forbes JF, 2001, 'Re: p53 protein detection in breast epithelium by immunohistochemistry [5]', Breast, vol. 10, pp. 263 - 265, http://dx.doi.org/10.1054/brst.2000.0194
2001
Millar EKA; Beretov J; Sarris M; Lee CS, 2001, 'Mucinous differentiation in colonic adenocarcinoma is associated with a reduction in tumour-infiltrating lymphocytes', European Journal of Surgical Oncology, vol. 27, pp. 273 - 277, http://dx.doi.org/10.1053/ejso.2000.1094
2001
Millar EKA; Leong ASY, 2001, 'Significance and assessment of margin status in ductal carcinoma in situ of the breast', Advances in Anatomic Pathology, vol. 8, pp. 338 - 344, http://dx.doi.org/10.1097/00125480-200111000-00004
2001
Millar EK; Beretov J; Sarris M; Clarke RA; Kearsley J; Lee CC, 2000, 'Malignant phyllodes tumours of the breast display increased stromal p53 protein expression.', Histopathology, vol. 34, pp. 491 - 496, http://dx.doi.org/10.1111/j.1365-2559.1999.00666.x
2000
Millar EKA; Waldron S; Spencer A; Braye S, 1999, 'CD10 positive thyroid marginal zone non-Hodgkin lymphoma', Journal of Clinical Pathology, vol. 52, pp. 849 - 850, http://dx.doi.org/10.1136/jcp.52.11.849
1999
Millar EK; Cappelen-Smith C; Sarris M; Clarke RA; Kearsley J; Lee CC, 1998, 'Prognostic factors in cutaneous malignant melanoma', Cancer Forum, vol. 22, pp. 178 - 180
1998
Millar EKA; Sharma NK; Lessells AM, 1996, 'Ductal (endometrioid) adenocarcinoma of the prostate: A clinicopathological study of 16 cases', Histopathology, vol. 29, pp. 11 - 19, http://dx.doi.org/10.1046/j.1365-2559.1996.d01-483.x
1996
Millar EKA, 1994, 'Prostatic Adenocarcinoma Metastatic To The Palatine Tonsil: A Case Report', The Journal of Laryngology & Otology, vol. 108, pp. 178 - 180, http://dx.doi.org/10.1017/S0022215100126234
1994
MILLAR EKA; JONES RV; LANG S, 1994, 'PROSTATIC ADENOCARCINOMA METASTATIC TO THE PALATINE TONSIL - A CASE-REPORT', JOURNAL OF LARYNGOLOGY AND OTOLOGY, vol. 108, pp. 178 - 180, http://dx.doi.org/10.1017/S0022215100126234
1994
Conference Abstracts
add
Gallego-Ortega D; Ledger A; Roden D; Cho C; Allerdice SL; Lee HJ; Valdes-Mora F; Lee B; Kaplan W; Salomon R; Piggin C; Rabinovich B; Millar E; Chtanova T; Swarbrick A; Clark S; Ormandy C, 2015, 'The ETS transcription factor ELF5 drives metastasis via angiogenesis and recruitment of Gr-1+ CD11b+ myeloid derived suppressor cells in luminal breast cancer', in Clinical and Experimental Metastasis, Springer Verlag (Germany), Vol. 32, pp. 203 - 203, presented at MRS 15th International biennial congress of the metastasis research society, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000351601900067&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2015
Graham PH; Browne L; Capp A; Delaney G; Fox C; Millar EK; Nasser E; Papadatos G, 2015, 'PREDICTORS OF RESPONSES AND SEXUAL FUNCTION FOR WOMEN IN THE ST GEORGE BREAST BOOST RANDOMIZED TRIAL (STGBBT)', in BREAST, CHURCHILL LIVINGSTONE, Vol. 24, pp. 304 - 304, http://dx.doi.org/10.1016/j.breast.2015.02.011
2015
Conference Papers
add
Rahbari RM; Xu H; Yan M; Patra J; Natrajan R; Yan Y; Swagemakers S; Tomaszewski J; Verschoor S; Miller EKA; Van der Spek P; Reis-Filho J; Ramsay R; O'Toole S; McNeil C; Sutherland R; McKay M; Fox S, 2014, 'Enhanced RAD21 Cohesin Expression Confers Poor Prognosis and Resistance to Chemotherapy in High Grade Luminal, Basal, and HER 2 Breast Cancers', in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, ELSEVIER SCIENCE INC, San Francisco, CA, pp. S812 - S813, presented at 56th Annual Meeting of the American-Society-for-Radiation-Oncology, San Francisco, CA, 14 September 2014 - 17 September 2014, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000342331403139&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2014
Pajic M; Graham PH; Millar EKA; O'Toole SA; Molloy TJ, 2013, 'MicroRNA-regulated pathways of radiotherapy sensitivity and resistance in breast cancer', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, Amsterdam, NETHERLANDS, pp. S232 - S232, presented at European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, NETHERLANDS, 27 September 2013 - 01 October 2013, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000326843601304&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2013
Millar EKA; Coates AS; O'Toole S; Selinger C; Musgrove EA; Yan M; Viale G; Regan MM; Price KN; Sun Z; Castiglione MM; Colleoni M; Gelber RD; Goldhirsch A; Sutherland RL, 2012, 'Intrinsic subtype and its clinical significance in early node-negative breast cancer: Results from two randomized trials of adjuvant chemoendocrine therapy.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Chicago, IL, presented at 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 01 June 2012 - 06 June 2012, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000318009800179&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2012
Molloy T; Pajic M; Holzhauser S; Graham P; Millar EKA; Sutherland RL, 2012, 'Identifying Putative MiRNAs Mediators of Radiotherapy Resistance in Breast Cancer', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, Barcelona, SPAIN, pp. S270 - S270, presented at 22nd Biennial Congress of the European-Association-for-Cancer-Research, Barcelona, SPAIN, 07 July 2012 - 10 July 2012, http://dx.doi.org/10.1016/S0959-8049(12)71723-9
2012
O Toole SJ; Swarbrick A; Millar E; McLeod D; Mcneil CM; Qiu MR; Lopez-Knowles E; Caldon E; Oakes SR; Ormandy CJ; Morey AL; Musgrove EA; Henshall SM; Sutherland RL, 2009, 'Aberrent hedgehog signaling is an early event in breast cancer development', in Cancer research, American Association Cancer Research, Philadelphia, PA, pp. 70S - 70S, presented at 31st Annual San Antonio Breast Cancer Symposium, San Antonio, TX, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000262583200031&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2009
Lopez-Knowles E; O'Toole SA; McNeil CM; Millar EKA; Qiu MR; Crea P; Daly RJ; Musgrove EA; Sutherland RL, 2009, 'PI3K Pathway Activation in Breast Cancer Is Associated with the Basal-Like Phenotype and Cancer-Specific Mortality', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, San Antonio, TX, pp. 632S - 632S, presented at 32nd Annual San Antonio Breast Cancer Symposium, San Antonio, TX, 09 December 2009 - 13 December 2009, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000272920701155&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2009